# qQ-lab Daily-IBS for Irritable Bowel Syndrome

> **NCT03964103** · NA · COMPLETED · sponsor: **IlDong Pharmaceutical Co Ltd** · enrollment: 100 (actual)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **DIETARY_SUPPLEMENT:** gQ-lab daily
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03964103
- **Lead sponsor:** IlDong Pharmaceutical Co Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-04
- **Primary completion:** 2017-11-08
- **Final completion:** 2018-01-22
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03964103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03964103, "qQ-lab Daily-IBS for Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03964103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*